Results 171 to 180 of about 58,247 (201)
Some of the next articles are maybe not open access.
2002
The therapy for atopic and vernal keratoconjunctivitis (AKC and VKC) is often not satisfactory. Conventional therapeutic regimens consist of anti-allergic substances. Topically used immunosupressives such as Cyclosporine A (CsA) eyedrops are still part of clinical trials.
I, Tomida +4 more
openaire +2 more sources
The therapy for atopic and vernal keratoconjunctivitis (AKC and VKC) is often not satisfactory. Conventional therapeutic regimens consist of anti-allergic substances. Topically used immunosupressives such as Cyclosporine A (CsA) eyedrops are still part of clinical trials.
I, Tomida +4 more
openaire +2 more sources
What's new in atopic keratoconjunctivitis
Acta Ophthalmologica, 2013AbstractSpecific clinical features of atopic keratoconjunctivitis are well known in adults and lead to a severe ocular surface impairment. However in children’s keratoconjunctivitis, even if common vernal keratoconjunctivitis form predominates, some pediatric presentation differs and must be individualised.
openaire +1 more source
[Treatment of atopic keratoconjunctivitis in childhood].
Klinische Monatsblatter fur Augenheilkunde, 1988In recent years atopic keratoconjunctivitis has been diagnosed increasingly frequently in children and adolescents. At Innsbruck University Eye Clinic all the children suffering from this condition have so far been satisfactorily treated with therapeutic contact lenses and locally applied antibiotics and steroids.
G F, Kieselbach, W, Gensluckner
openaire +1 more source
Association between atopic keratoconjunctivitis and the risk of keratoconus
Acta Ophthalmologica, 2021Yuh-Shin Chang +2 more
exaly
Atopic Keratoconjunctivitis: Diagnosis and Treatment
Current Ophthalmology Reports, 2022Sana Qureshi, Nandini Venkateswaran
openaire +1 more source